Hans M Borchgrevink MD MHA Senior adviser The Research Council of Norway

1. SMEs: their need for strategic information - challenges and opportunities for SMEs within the life science cluster Hans M Borchgrevink MD MHA Senior adviser The Research Council of Norway

2. The Research Council of Norway Director General Staff International staff Administration Communication Division forScience Division for StrategicPriorities Division for Innovation

3. Division for Science Social Sciences Humanities Division director Physical Sciences and Technology Staff Biology and Biomedicine Clinical Medicine and Public Health

4. Division for Strategic Priorities Future Technologies Society and Public Policy Division Director Environmental Issues, Energy and Sustainable Development Staff Marine Resources and Environment

5. Division for Innovation Promotion of R&D and Commercialisation Manufacturing, ICT and Services Division Director Biotechnology, Food Scienceand Tax Incentive Schemes Staff Agricultural and Marine Research Energy, Petroleum and Maritime Research

6. Total budget by divisions mill. NOK (2004) adm. misc. Division forScience Division for Innovation Division forStrategicPriorities Total NOK 4 616 million (administration incl.)

7. Total budget by activities (2004) Miscellaneous Infrastructure Programmes Independent projects Total NOK 4 616 million (administration incl.)

8. Funding from the ministries (2004) Administration The Research Fund Ministry of Education and Research Miscellaneous ministries Ministry of Environment Ministry of Trade and Industry Ministry of Agriculture Ministry of Petroleum and energy Ministry of Fisheries Total NOK 4 616 million (administration incl.)

9. Budget development (1993-2004) Mill. NOK 1993-NOK

10. R&D expenses in NorwayversusRCN budget (bill.NOK) 1Prognoser for FoU-utgifter i 2003 Kilde: Indikatorrapporten, Norges forskningsråd

11. R&D expenses in % of GNP for the Nordic countries compared with OECD mean Sweden Finland Iceland Denmark OECD-snitt Norway

12. The relation between GNP and R&D expenses 1991-2003 for Norway 1Prognoser for FoU-utgifter i 2003 Kilde: Indikatorrapporten

13. R&D expenses (2001) for OECD countries in NOK per inhabitant and in % of GNP

14. Governmental R&D expenses (2001) for OECD countries – in NOK per inhabitant and in % of GNP

15. % annual growth in R&D expenses 1995-2001 for the Nordic, USA, OECD

16. Sweden Finland Japan USA Iceland Germany Denmark Belgium Luxembourg France EU15 UK Austria Netherlands Norway Irland Italy Spain R&D in private enterprises% of GNP 2001 0,0 % 1,0 % 2,0 % 3,0 %

17. Nordic innovative enterprises in % of total number of enterprises (2001)

18. New/improved products as % of total turnover (2000; Norway 2001) Norway France Finland Austria Germany %

19. High- and medium-tech exports in % of total industrial exports (2001) High-tech Iceland Norway Denmark Finland Sweden USA Irland Japan Medium-tech %

20. R&D investments by private enterprises in % of GNP % Sweden Finland Denmark OECD-mean Norway

21. Nordic scientific papers in international journals - per 100.000 inhabitants Sweden Finland Iceland Denmark Norway

22. Scientific publications from Norway with and without international co-author 1983-2002 Kilde: Science Citation Index

23. Scientific publications co-authored by Norwegian researchers by countries of collaboration EU except the Nordic North-America The Nordic Other countries Former Eastern Europe Kilde: Science Citation Index

24. Nordic Science Citation Index Denmark Sweden Finland World mean=1 Norway

25. SMEs go LifeSciences 1 • FP6 SSA (Specific Support Action) • Programme: Research and innovation • ETI (Economic and Technological Intelligence)

26. HRM i 6RP

27. SMEs go LifeSciences 2 • Objective: to support and foster the participatioin of SMEs and SME groupings in Life Sciences projects of the EU FP6, particularly in- IPs (Integrated Programmes)- NoE (Networks of Excellence)- STREPS (Specific targeted research projects) • Goal: SMEs should have 15% of budgets in FP6 LifeSciences (now only 8%)

28. SMEs go LifeSciences 3 • 18 mill. SMEs in Europe • 95% of European enterprises are SMEs • SMEs contribute to appr. 2/3 of employment and economic turnover in Europe • However,Only 4% of EoI submitters to FP6 LifeScienceswere from industry incl SMEs • Targeted, tailored support for SMEs is needed

29. SMEs go LifeSciences 4 • 28 partners from 26 countries- 12 members states- 10 candidate countries- 4 associated states (incl Switzerland) • Main activities:Capacity building and training- for SMEs and SME groupings- for researchers on how to involve SMEs Consortium building and match-makingfor SMEs and researchers preparing proposals

30. SMEs go LifeSciences 5 • Activities: • Promote transregional co-operation between SMEs • Stimulate networks of Life Sciences incubators and biovalleys • Facilitate the creation of co-operations and groupings of SMEs with similar innovation needs

31. SMEs go LifeSciences 6 • To support and foster the participatioin of SMEs and SME groupings in Life Sciences projects of the EU FP6 within the relevant Thematic Priorities (TPs), i.e.- TP 1 Life Sciences, Genomics and Biotechnologiesand in relevant parts of- TP 2 IST – e.g. bioinformatics- TP 3 Nanotechnologies- TP 5 Food quality and safety(11 partners also participates in the complementary ETI ”SMEsforFOOD”

32. SMEs go LifeSciences 7 • SMEs will receive direct support, assistance and coaching for successful participation in FP6 • Increasing visibility and Match-making will be made through preparation of- SME (activity) profile forms - FP6 profile formsfor electronic storage in catalogues for partner search also in search for partners to enter ongoing projects • Seminars - trans-national, and with national follow-ups - will be organised on SME-relevant topics (e.g. IPR)for dissemination of information for SME coaching

33. SMEs go LifeSciences 8 • Outcome envisaged: The project aims to- contact 2500 SMEs and SME groupings- enter 250 high-quality SME profiles into the database- contact 400 FP6 researchers/coordinators- enter 100 researcher/coordinator/proposal/project profiles into the database- make 300 consortiae take in at least one additional SME partner- and thereby contribute to the creation of the European research Area (ERA)

34. SMEs go LifeSciences 9 • The project will recruit SMEs by visiting universities and research parks/ incubators/ biovalleys • The international kick-off meeting was held in Warsaw late March 2004 • The Norwegian project is run by the RCN, had kick-off late March 2004 and includes- a part-time project manager (HM Borchgrevink)- a steering group (RCN representatives)- a reference group (universities/incubators/innovation-/biotech organisation)

35. SMEs go LifeSciences 10 • We want to run the project in close contact with - the Norwegian universities, research parks, incubators, innovation units and biotech organisations - other Nordic networking activities in the field of Life Sciences (e.g. MedCoast, ScanBalt, MediconValley, STRATINC) • which is in line with the recent Nordic political initiatives to promote a Nordic Research & Innovation Area (NORIA) to obtain synergy and ”critical mass”